Clinical Trial Update: APX005M and Doxorubicin in Advanced Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating APX005M in combination with doxorubicin for advanced soft tissue sarcoma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• APX005M
• Doxorubicin (doxorubicin)

Snippet

Sponsor: Alexander Z. Wei, MD | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING